As direct-to-consumer microbiome testing becomes more popular, clinicians are calling for stronger scientific and clinical standards to ensure results are accurate, reproducible, and clinically meaningful. The article highlights growing evidence that different companies can generate markedly different results from the same stool sample, raising concerns about inconsistent interpretations and patient confusion. It also points to recent international consensus recommendations that emphasize standardized testing methods, transparent reporting, and clinically validated use cases, arguing that the future of microbiome testing should focus less on cataloging bacteria and more on understanding microbial function and its impact on patient care.
Microbiome Testing Needs Its Standards Moment (Op-Med)
0
